Boston Scientific ($BSX) terminated its prior 2021 Revolving Credit Agreement on Feb 26, 2026 after…
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific ($BSX) terminated its prior 2021 Revolving Credit Agreement on Feb 26, 2026 after entering a new 2026 Revolving Credit Agreement. Prior RCF dated May 10, 2021 (amended Dec 21, 2022; Mar 1, 2023; May 10, 2024). Wells Fargo NA was administrative agent. 🔁🏦 #CreditFacility #Debt
Termination effective Feb 26, 2026; parties were the Company (borrower), the several lenders and Wells Fargo Bank, N.A. as administrative agent. See Boston Scientific 10‑K (filed Feb 17, 2026) for the full agreement and amendments (Exhibits 10.1–10.4). 📄🔍 $BSX #Regulatory #CreditFacility
Investor takeaway: the 2021 RCF has been replaced by a 2026 Revolving Credit Agreement — review the 10‑K exhibits for material terms (commitments, rates, covenants) to assess impact on liquidity and financing. 📑💡 $BSX #Debt #CorporateFinance